CJChristopher S. Jones

Christopher S. Jones

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Christopher S. Jones has a total of 18 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Complete Mitochondrial Genome and Phylogenetic Position of the Pacific Spiny Dogfish Squalus suckleyi (Squaliformes: Squalidae)

    by Laure Inçaby, Sabrina Haney, Michael Phelps, Catherine S. Jones, Marcela Uliano‐Silva, Galice Hoarau, Leslie R. Noble

    The Pacific spiny dogfish, Squalus suckleyi (Girard, 1854), is a benthopelagic small shark widely distributed across the North Pacific, caught in both commercial and bycatch fisheries throughout its range. Here we report the first mitochondrial genome of Squalus suckleyi , assembled from PacBio high‐fidelity sequencing reads. The mitogenome (GenBank accession PZ086324) is 16,738 base pairs long and comprises the typical set of 37 mitochondrial genes found in vertebrates, including 13 protein‐coding genes, 22 transfer RNA genes, two ribosomal RNA genes and a control region. The overall nucleotide composition is AT‐biased (A + T content of 61.17%), consistent with other elasmobranchs. Maximum‐likelihood phylogenetic analysis based on the 13 protein‐coding genes recovered S. suckleyi as sister to S. acanthias with maximum ultrafast bootstrap support. Pairwise non‐synonymous to synonymous substitution rate ratios between S. suckleyi and S. acanthias ranged from 0 to 0.051 across all protein‐coding genes, suggesting strong purifying selection on mitochondrial function in this recently diverged species pair. This mitogenome provides a high‐quality genomic resource to support phylogeographic, evolutionary and management‐oriented studies of Squalus suckleyi and more broadly the Squaliformes.

  • Size-dependent growth of individual Atlantic salmonSalmo salaralevins from hatch to first feeding

    by J. Gilbey, E. Cauwelier, C. S. Jones, A. Mclay, L. R. Noble, E. Verspoor

    Variation in egg size, hatch timing and size at hatch, and their influence on individual growth rates of Atlantic salmon Salmo salar alevins up to first feeding were examined in pure strain and hybrid crosses of fish from Scotland and Canada. At the intra-female, intra-cross type and inter-cross type levels, specific growth rates prior to first feed were strongly size dependent, with smaller and later hatching alevins growing significantly faster. The magnitude of this size-dependent growth was greatest in the hybrid crosses. This resulted in a 40% reduction in the coefficient of variation (c.v.) in alevin size from post-hatch to first feeding at the intra-female level, and a reduction of both intra- and inter-cross differences in alevin sizes in the same period.


  • Safety and Immunogenicity of a Recombinant Protein Influenza A Vaccine in Adult Human Volunteers and Protective Efficacy against Wild-Type H1N1 Virus Challenge

    by Louis F. Fries, Susan B. Dillon, James E. K. Hildreth, Ruth A. Karron, Ann W. Funkhouser, Carl J. Friedman, Christopher S. Jones, Vasantha G. Culleton, Mary Lou Clements

    A recombinant influenza A vaccine (D protein), comprising a carboxy-terminal sequence from the hemagglutinin HA2 subunit of A/Puerto Rico/8/34 virus (HINl, A/PR/34) fused to 81 amino-terminal residues of the NSI nonstructural protein, has previously protected mice against influenza A challenge by inducing HINl/H2N2 cross-reactive cytotoxic T cells (CTL) without hemagglutination-inhibiting (HI) or neutralizing antibody. In our dose-escalating study, the vaccine was safe in humans and induced both IgG and T cell proliferative responses to D protein but little antibody to A/PR/34 or A/Kawasakij8/86 (HINl, A/KW/86) viruses. Among an additional group of A/KW/86-seronegative volunteers immunized with 500 µg of D protein, none had a rise in serum HI or neutralizing antibody to A/KW/86, 20% had minimal IgG responses to A/KW/86 by EIA, and a minority had any increase in A/KW/86-specific CTL activity. However, viral shedding and clinical illness score were reduced in vaccinees relative to A/KW/86-seronegative unimmunized controls after intranasal challenge with wild-type A/KW/86. D protein immunization conferred significant protective immunity not currently explained by any of the immune parameters measured.